Management and Outcomes of ANCA-Associated Vasculitis at a Tertiary Healthcare Facility

RESULTS: Thirty-six patients were included in the final study. Cyclophosphamide was used in 24 patients (66.7%) and, comparatively, rituximab in 7 patients (19.4%) for induction. Seven patients (19.4%) had a documented relapse, and six patients (85.7%) had rituximab as induction therapy for relapse....

Descripción completa

Detalles Bibliográficos
Autores principales: Moollan, Nabeehah, Ahmed, Adeel Rafi, Denton, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856824/
https://www.ncbi.nlm.nih.gov/pubmed/35186331
http://dx.doi.org/10.1155/2022/4808806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856824/
https://www.ncbi.nlm.nih.gov/pubmed/35186331
http://dx.doi.org/10.1155/2022/4808806

Ejemplares similares